Concepedia

Sebastian Kallus

SK

Statistics

Publications

7

Citations

241

H-Index

7

Active since

2016

Affiliations

University of Vienna(Current)

Medical University of Vienna

Comprehensive Cancer Center Vienna

Institute of Cell Biology

National Academy of Sciences of Ukraine

Sebastian Kallus is an author at University of Vienna specializing in pharmacology, oncology, and molecular oncology.

Publications per year

2016–2020

7

Publications

7

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Bernhard Englinger, Sebastian Kallus, Julia Senkiv et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 61 citations · Full text

Medicine, Oncology, Pharmacology +14

Impact of Stepwise NH<sub>2</sub>-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention

Christian R. Kowol, Walter Miklos, Sarah Pfaff et al. · Journal of Medicinal Chemistry · 2016 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes

Sebastian Kallus, Lukas Uhlik, Sushilla van Schoonhoven et al. · Journal of Inorganic Biochemistry · 2018 · 43 citations

Pharmacy, Medicinal Chemistry, Oncology +13

Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index

Sebastian Kallus, Bernhard Englinger, Julia Senkiv et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 34 citations · Full text

Medicine, Oncology, Pharmacology +14

Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

Bernhard Englinger, Anna Laemmerer, Patrick Moser et al. · International Journal of Cancer · 2020 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 7